Dr. Jeffrey Apter participated at Global Site Solutions Summit in Florida this weekend

Dr. Apter participated in Global Site Solutions Summit

Last week, the 2017 Global Site Solutions Summit opened its doors to professionals of clinical trials industry. The Summit pursued the objective to engage industry leaders from CROs, Pharma companies, study sites and regulatory authorities in a dynamic dialogue and allowed them to directly interact with each other.

Every year brings new inventions, discoveries and advanced solutions to facilitate and improve sites’ operations and procedures. This year’s topics include enrollment issues, clinical data collection and management at all levels, inspections and many others. Site partnership symposiums were focused on promoting knowledge and mobilizing insight into study pipeline opportunities and site sustainability.

Operating globally in 8 countries, GCT is a CRO that gained an impressive background of successfully completed studies in CNS, gastroenterology, oncology, ophthalmology, reproductive health and rare diseases. GCT President Dr. Jeffrey Apter, a Principal Investigator of over 100 trials in Depression, Anxiety, Bipolar Disorder, Schizophrenia and Alzheimer’s Disease, is closely aware of  issues that sites come across in their everyday activities. Please contact bd@gctrials.com to schedule a face-to-face meeting with Dr. Apter at the next event to share best practices and discuss your clinical development plans.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2018 Global Clinical Trials, LLC

All rights reserved.